Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
histidine-rich calcium binding protein
(
HRC
) is a novel regulator of sarcoplasmic reticulum (SR) Ca(2+)-uptake, storage and release. Residing in the SR lumen,
HRC
binds Ca(2+) with high capacity but low affinity. In vitro phosphorylation of
HRC
affects ryanodine affinity of the ryanodine receptor (RyR), suggesting a functional role of
HRC
on SR Ca(2+)-release. Indeed, acute
HRC
overexpression in isolated rodent cardiomyocytes decreases Ca(2+)-induced Ca(2+)-release, increases SR Ca(2+)-load, and impairs contractility. The
HRC
effects on RyR may be regulated by the Ca(2+)-sensitivity of its interaction with triadin. However,
HRC
also affects the SR Ca(2+)-ATPase, as shown by
HRC
overexpression in transgenic mouse hearts, which resulted in reduced SR Ca(2+)-uptake rates, cardiac remodeling and hypertrophy. In fact, in vitro generated evidence suggests that
HRC
directly interacts with SR Ca(2+)-ATPase2, supporting a dual role of
HRC
in Ca(2+)-homeostasis: regulation of both SR Ca(2+)-uptake and Ca(2+)-release. Furthermore,
HRC
plays an important role in myocyte differentiation and in antiapoptotic cardioprotection against
ischemia
/reperfusion induced cardiac injury. Interestingly,
HRC
has been linked with familiar cardiac conduction disease and an
HRC
polymorphism was shown to associate with malignant ventricular arrhythmias in the background of idiopathic dilated cardiomyopathy. This review summarizes studies, which have established the critical role of
HRC
in Ca(2+)-homeostasis, suggesting its importance in cardiac physiology and pathophysiology.
...
PMID:Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling. 2080 42